The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2022
DOI: 10.1080/20477724.2022.2128563
|View full text |Cite
|
Sign up to set email alerts
|

Intermittent preventive treatment with Sulfadoxine pyrimethamine for malaria: a global overview and challenges affecting optimal drug uptake in pregnant women

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
2
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 128 publications
1
2
0
1
Order By: Relevance
“…IPT protected parturient from malaria attack, evidenced by the fact that the proportion of parturient who took IPT and still had malaria attack was about (40.1%) compared to (47.8%) of the pregnant women who did not take IPT but rather made use ITNs. This result agreed with a study where those who took IPT 23% still have malaria infection compared to 78% of those who did not take IPT, a significant observation in keeping with other studies in Nigeria [4] and elsewhere [41] .…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…IPT protected parturient from malaria attack, evidenced by the fact that the proportion of parturient who took IPT and still had malaria attack was about (40.1%) compared to (47.8%) of the pregnant women who did not take IPT but rather made use ITNs. This result agreed with a study where those who took IPT 23% still have malaria infection compared to 78% of those who did not take IPT, a significant observation in keeping with other studies in Nigeria [4] and elsewhere [41] .…”
Section: Discussionsupporting
confidence: 92%
“…Malaria in pregnancy is a colossal unrestricted health predicament that affects about 25 million women in malaria-endemic areas every year [2,3] . Pregnant women, mostly primigravidae and secundigravidae are predominantly susceptible to malaria than nonpregnant women from the same area [4] . Malaria in pregnancy has remained the major source of maternal, infant morbidity and mortality, though it is an avertable and transmittable disease.…”
Section: Introductionmentioning
confidence: 99%
“…After sequence alignment nucleotide positions which displayed two peaks at one locus in chromatogram were noted as ‘‘mixed’’ and excluded from further analysis. Known point mutations in P. falciparum genes associated with anti-malarial drug resistance (CQ, SP, ART and its derivatives), and novel mutations were identified using their corresponding amino acids and haplotypes [ 8 , 36 ]. Regarding P. vivax isolates, putative drug resistance-associated mutations were also investigated [ 37 40 ] (Table 1 ).…”
Section: Methodsmentioning
confidence: 99%
“…Для хлоридина характерен длинный период полувыведения, который составляет 80-100 часов. У пациентов с длительный курсом лечения хлоридином из побочных эффектов чаще всего встречаются симптомы анемии [47].…”
Section: противомикробная антигрибковая и противопаразитарная активностьunclassified